March 01, 2021
By Marco Meglio
The authors noted that future studies evaluating the time course of fatigue in patients with multiple sclerosis are needed.
March 01, 2021
By NeurologyLive Staff
Here's what is coming soon to NeurologyLive.
February 28, 2021
By Matt Hoffman
Clene Nanomedicine’s nanocatalyst agent CNM-Au8 displayed significant improvements in patients with EDSS scores of 2.0 or higher compared to those with EDSS scores of 1.5 or lower.
February 27, 2021
By Victoria Johnson
Researchers from Massachusetts General Hospital found that DMT-treated patients were, on average, younger than untreated patients.
February 27, 2021
By Marco Meglio
Higher concealment behavior for patients with multiple sclerosis was associated with higher anxiety, but not depression.